Last reviewed · How we verify

NCT05318053: IKHS

International Kink Health Study

Completed Last updated 24 February 2025
What this trial tests

trial in Wounds and Injuries in 917 participants. Completed in 31 March 2024.

Timeline
1 June 2022
Primary endpoint
31 March 2024
31 March 2024

Quick facts

Lead sponsorThe Alternative Sexualities Health Research Alliance
StatusCompleted
Study typeOBSERVATIONAL
Enrollment917
Start date1 June 2022
Primary completion31 March 2024
Estimated completion31 March 2024
Sites1 location across United States

Conditions studied

Sponsor

The Alternative Sexualities Health Research Alliance

Who can join

18 and older, any sex, with Wounds and Injuries or Mental Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study design is an observational, longitudinal study with data collected online via a computer-assisted survey. Subjects will be recruited through non-probability snowball sampling. Objectives: 1. to document the prevalence of injuries and medical complications arising from kink activities 2. to document how healthcare is utilized by kink-involved people 3. to document the health outcomes particular to a large sample of kink-involved people 4. to test whether the centrality of kink identity and degree of community belongingness affect injuries, health outcomes, and healthcare utilization

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Wounds and Injuries

Currently open trials in the same condition.

Other The Alternative Sexualities Health Research Alliance trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05318053.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing